Skip to main content

Kaiser Richard Kaiser's Form 4 filing

Bioforce Nanosciences Holdings, Inc. (BFNH) · filed Sep 2, 2026

Accession no.
0001091818-26-000133
Filed
Sep 2, 2026, 4:04 PM ET
Trade date
Apr 20-Aug 31, 2026
Filing delay
135 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 0 derivative transactions. It was filed 135 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kaiser Richard KaiserCIK 0001663787Director, Officer (CEO & CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 20, 2026Common Stock; Par Value $0.001GGiftDisposed−4,132,000$0.001−$4,132956,000Direct
Aug 20, 2026Common Stock; Par Value $0.001JOtherDisposed−38,462$0.65−$25,000.3917,538Direct
Aug 31, 2026Common Stock; Par Value $0.001AGrant or awardAcquired+316,909$0.55+$174,299.951,234,447Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)